MedTrace Logo

Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012

NCT03586037 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2018-10-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the Pharmacokinetic Interaction Between AD-2011 and AD-2012 in healthy male volunteers.

Conditions

Interventions

DRUG

AD-2011 10/20 mg

AD-2011 10/20 mg tablet

DRUG

AD-2012 80mg

AD-2012 80mg tablet

DRUG

AD-2011 10/20 mg + AD-2012 80mg

AD-2011 10/20 mg + AD-2012 80mg tablet

Sponsors & Collaborators

  • Addpharma Inc.

    lead INDUSTRY

Principal Investigators

  • In-Jin Jang, M.D., Ph.D · Seoul National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-12
Primary Completion
2018-08-09
Completion
2018-08-20

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03586037 on ClinicalTrials.gov